{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:29:08Z","timestamp":1793651348975,"version":"4.5.1"},"reference-count":8,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Toxicology Reports"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.toxrep.2026.102320","type":"journal-article","created":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T15:12:11Z","timestamp":1784733131000},"page":"102320","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Encephalopathy following subcutaneous administration of Brixadi\u00ae extended-release buprenorphine"],"prefix":"10.1016","volume":"17","author":[{"given":"Justin","family":"Seltzer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riku","family":"Moriguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kara","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuri","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Hardin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Galust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Minns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.toxrep.2026.102320_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2025.113011","article-title":"Outpatient initiation of direct-to-inject buprenorphine","volume":"278","author":"Rosenwohl-Mack","year":"2026","journal-title":"Drug. Alcohol. Depend."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102320_bib2","doi-asserted-by":"crossref","DOI":"10.57264\/cer-2025-0171","article-title":"Effectiveness and safety of therapies for patients with opioid use disorder: a systematic review and network meta-analysis","volume":"15","author":"Kabra","year":"2026","journal-title":"J. Comp. Eff. Res."},{"issue":"12","key":"10.1016\/j.toxrep.2026.102320_bib3","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s11916-023-01185-4","article-title":"Buprenorphine for Chronic Pain Management: a Narrative Review","volume":"27","author":"Vu","year":"2023","journal-title":"Curr. Pain. Headache Rep."},{"key":"10.1016\/j.toxrep.2026.102320_bib4","unstructured":"United States Food and Drug Administration. BRIXADI\u00ae (buprenorphine) extended-release injection for subcutaneous use CIII. Revised 12\/2025. Accessed from: https:\/\/www.brixadihcp.com\/pdfs\/brixadi-prescribing-information.pdf."},{"issue":"2","key":"10.1016\/j.toxrep.2026.102320_bib5","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1097\/ADM.0000000000001279","article-title":"The Devil's in the Depot Details: Case of Iatrogenic Opioid Intoxication After Buprenorphine Injection Requiring Surgical Excision","volume":"18","author":"Vais","year":"2024","journal-title":"J. Addict. Med."},{"issue":"6","key":"10.1016\/j.toxrep.2026.102320_bib6","doi-asserted-by":"crossref","first-page":"2996","DOI":"10.1111\/bcp.15196","article-title":"An unusual case of buprenorphine overdose secondary to sibling play: Examining how medication delivery devices appear to children","volume":"88","author":"O'Reilly","year":"2022","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"22","key":"10.1016\/j.toxrep.2026.102320_bib7","doi-asserted-by":"crossref","first-page":"7341","DOI":"10.1523\/JNEUROSCI.3723-08.2009","article-title":"Buprenorphine is a weak partial agonist that inhibits opioid receptor desensitization","volume":"29","author":"Virk","year":"2009","journal-title":"J. Neurosci."},{"issue":"5","key":"10.1016\/j.toxrep.2026.102320_bib8","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/clpt.1994.71","article-title":"Clinical pharmacology of buprenorphine: ceiling effects at high doses","volume":"55","author":"Walsh","year":"1994","journal-title":"Clin. Pharmacol. Ther."}],"container-title":["Toxicology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001228?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214750026001228?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T19:58:52Z","timestamp":1793649532000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214750026001228"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":8,"alternative-id":["S2214750026001228"],"URL":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102320","relation":{},"ISSN":["2214-7500"],"issn-type":[{"value":"2214-7500","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Encephalopathy following subcutaneous administration of Brixadi\u00ae extended-release buprenorphine","name":"articletitle","label":"Article Title"},{"value":"Toxicology Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.toxrep.2026.102320","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"102320"}}